
Retatrutide vs GLP-1 Drugs: What’s Different?
Retatrutide has become one of the most discussed investigational medications in obesity and metabolic-health research because it aims to do something that earlier “incretin-based” drugs only partially achieved: reduce appetite and meaningfully increase energy expenditure through a multi-hormone approach. It








